mergers and acquisitions

Showing 15 posts of 21 posts found.


Transactions in the pharma sector: Through the EU merger review looking-glass

October 31, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing mergers, mergers and acquisitions, pharma

With mergers and acquisitions back in full swing after a period of drought, Alec Burnside (Partner) and Delphine Strohl (Associate) …


Amgen open to larger M&A deals, says CFO

March 8, 2016
Sales and Marketing Amgen, mergers and acquisitions

Amgen’s chief financial officer has indicated that the company is ready to consider doing larger deals to buy other companies, …


Pharma: How to make mergers work

January 29, 2016
Sales and Marketing mergers and acquisitions

Pharma is no stranger to bursts of M&A activity.

Shire and Baxalta reach $32 billion merger agreement

January 11, 2016
Manufacturing and Production, Sales and Marketing Baxalta, Shire, mergers, mergers and acquisitions

One of the industry’s longest-running M&A sagas has finally reached a conclusion, with Shire and Baxalta announcing a $32 billion …


Perrigo rejects $26 billion hostile Mylan takeover bid

November 13, 2015
Medical Communications, Sales and Marketing Mylan, Perrigo, mergers and acquisitions

Perrigo has rejected Mylan’s hostile $26 billion bid after a 60% majority of shareholders were unconvinced by the terms by …


AmerisourceBergen acquires sterile compounder PharMEDium for $2.5bn

October 7, 2015
Research and Development, Sales and Marketing AmerisourceBergen, mergers and acquisitions

AmerisourceBergen will now source compounded drugs for its hospital clients by manufacturing them itself after spending more than $2.5 billion …


Cardinal Health completes $1.944bn acquisition of J&J’s Cordis

October 6, 2015
Manufacturing and Production, Sales and Marketing Cardinal Health, Cordis, mergers and acquisitions

Cardinal Health has completed the acquisition of Johnson & Johnson’s Cordis business: a global leader in cardiology and endovascular devices, …


Teva acquires Mexico’s Rimsa for $2.3 billion

October 5, 2015
Research and Development, Sales and Marketing Mexico, Rimsa, Teva, mergers and acquisitions

Strategic Move Enhances Teva’s Presence in Mexico, the Second Largest Market in Latin America and a Major Emerging Market Brings a Portfolio of …

North 51 acquired by Bionical

October 5, 2015
Bionical, North 51, mergers and acquisitions

North 51 Ltd, a Nottingham-based healthcare company has been acquired by Bionical in a multi-million pound deal. The North 51 …


Actelion confirms takeover talks with ZS Pharma

September 11, 2015
Research and Development, Sales and Marketing Actelion, Shire, ZS Pharma, mergers and acquisitions

Swiss drugmaker Actelion has entered discussions with US biotech company ZS Pharma, over a takeover thought to be worth $2.5 …


Pfizer completes $15 billion Hospira acquisition

September 4, 2015
Biosimilar Drugs, Hospira, Pfizer, mergers and acquisitions

Pfizer has completed its acquisition of Illinois-based injectable drugs and infusion device specialist Hospira for around $15 billion.The deal, first announced …

Novo Nordisk to buy two pharma research companies

August 27, 2015
Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, mergers and acquisitions

Novo Nordisk is to acquire two privately-held biopharmaceutical research companies specialising in diabetes, for undisclosed sums. Calibrium and MB2, formed …


Abbott to table $25bn bid for medical device maker St Jude?

August 27, 2015
Manufacturing and Production, Sales and Marketing Abbott Laboratories, mergers and acquisitions, st jude medical

Abbott Laboratories is said to be preparing a $25 billion takeover bid for medical device maker St Jude Medical.  Illinois-based Abbott …


Depomed rejects Horizon’s latest takeover bid

July 30, 2015
Sales and Marketing Depomed, horizon, mergers and acquisitions, takeovers

Depomed has rejected Horizon Pharma’s latest bid, stating the proposal is ‘inadequate’ and ’undervalues’ the company. The Irish pharma company …


Teva to switch generics focus to Allergan

July 27, 2015
Sales and Marketing Allergan, Teva, generics, mergers and acquisitions, pharma mergers and acquisitions

Teva is in negotiations to buy Allergan’s generics division for upwards of $40 billion, according to reports. The generics firm …

Latest content